2005 Ankara University Faculty of Medicine

2011 Ankara University Faculty of Medicine Internal Medicine Specialist

2013 Dr. A. Y. Ankara Oncology EAH Medical Oncology Specialization

Specialization Thesis in Medicine: EFFECTS OF TELMISARTAN ON BONE CYCLE MARKERS

2006-2001 Ankara University Faculty of Medicine, Department of Internal Diseases (Internal Diseases Research Assistant)

2011-2012 Dr. Nafiz Körez Sincan State Hospital (Internal Medicine Specialist)

2012-2013 Polu District State Hospital (Internal Medicine Specialist – Chief Physician)

2013-2019 Abdurrahman Yurtaslan Ankara Oncology EAH Medical Oncology Clinic (Medical Oncology Minor Assistant)

2016-2021 Dr. Abdurrahman Yurtaslan Ankara Oncology EAH Medical Oncology Clinic (Medical Oncology Specialist)

Turkish Medical Oncology Association

Ankara Breast Diseases Association

A1. Eraslan, E., Yildiz, F., Ilhan, A., & Dogan, M. (2021). The Need for Effective Adjuvant Therapy in Uterine Leiomyosarcoma: A Single-centre Experience. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP, 31(8), 926-931. https://doi.org/10.29271/jcpsp.2021.08.926

A2. Eraslan, E., Doğan, M., Yildiz, F., İlhan, A., & Öksüzoğlu, Ö. B. (2021). Treatment options after regorafenib failure in metastatic colorectal cancer. European review for medical and pharmacological sciences, 25(9), 3470–3477. https://doi.org/10.26355/eurrev_202105_25828

A3. Eraslan, E., Adas, Y. G., Yildiz, F., Gulesen, A. I., Karacin, C., & Arslan, U. Y. (2021). Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP, 30(4), 399-404. doi: 10.29271/jcpsp.2021.04.399.

A4. Eraslan, E., & Arslan, U. Y. (2020). Long-term follow-up results of patients with sarcomatoid RCC: A retrospective evaluation of a single center experience. Journal of Surgery and Medicine, 4(9), 803-807. doi: 10.28982/josam.789516.

A5. Eraslan, E., & Doğan, M. (2021). Platelet-to-lymphocyte Ratio (PLR) as an Indicator of Survival in Rare Histopathological Subtypes of Renal Cell Carcinoma. Medical Science and Discovery, 8(4), 283-288. doi: 10.36472/msd.v8i4.535.

A6. Sütcüoğlu O, İlhan A, Tacar SY, Güven DC, Uçar G, Karadurmuş N, Yıldız F, Eraslan E, Uncu D, Tural D, Üner A, Günel N, Özdemir N, Kılıçkap S, Öksüzoğlu ÖB, Abstract A, Yazıcı O Thirty-day mortality rates after immunotherapy initiation. Immunotherapy. 2021 Oct 22. doi: 10.2217/imt-2021-0082. Epub ahead of print. PMID: 34676791.

A7. Helvaci, K., Eraslan, E., Yildiz, F., Tufan, G., Demirci, U., Berna Oksuzoglu, O., & Yalcintas Arslan, U. (2019). Comparison of clinicopathological and survival features of right and left colon cancers. J. BUON Off. J. Balk. Union Oncol, 24, 1845-1851.

A8. Yildiz, F., Eraslan, E., Ilhan, A., Demir, H., Demir, N., Erdur, E., ... & Demirci, U. (2020). Perioperative Docetaxel, Oxaliplatin, Fluorouracil, and Leucovorin (FLOT) in Patients with Gastric or Esophagogastric Junction Adenocarcinoma; Real-Life Experience. International Journal of Hematology & Oncology/UHOD: International Journal of Hematology & Oncology, 30(3). doi: 10.4999/uhod.

A9. Ozcelik, M., Seker, M., Eraslan, E., Koca, S., Yazilitas, D., Ercelep, O., ... & Aliustaoglu, M. (2016). Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology. Tumor Biology, 37(4), doi: 5231-5237. 10.1007/s13277-015-4359-1.

A10. Yildiz, F., Durnali, A., Eraslan, E., Ilhan, A., Tufan, G., Aslan, F., ... & Oksuzoglu, B. (2020). Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey. Urology Journal, 6004-6004. doi: 10.22037/uj.v16i7.6004.

A11. Yıldız, F., İlhan, A., Eraslan, E., Aslan, F., Tufan, G., Öksüzoğlu, B., & Demirci, U. (2020). Single Center Experiences with Pegfilgrastim as Secondary Prophylaxis. Turkish Journal of Oncology, 35(2), doi: 10.5505/tjo.2019.2087.

A12. Aslan, F., Demirci, U., Kızılgöz, D., Yıldız, F., Kabalak, P. A., Başal, F. B., Eraslan, E., Yılmaz, Ü., & Öksüzoğlu, B. (2020). Prognostic factors affecting survival in third-line treatment of advanced non-small cell lung cancer: Retrospective cohort study. Journal of Surgery and Medicine 2020;4(2):135-138. doi: 10.28982/josam.686819.

A13. Ekinci, A. Ş., Bal, Ö., Özatlı, T., Türker, İ., Eşbah, O., Demirci, A., Budakoğlu, B., Arslan, Ü. Y., Eraslan, E., & Öksüzoğlu, B. (2014). Gastric carcinoma with bone marrow metastasis: a case series. Journal of gastric cancer, 14(1), 54. doi: 10.5230/jgc.2014.14.1.54.

Değerli Yorumlarınızı Bekliyoruz.